Legal & General Group
RCEL icon

Legal & General Group’s Avita Medical RCEL Stock Holding History

Legal & General Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.8K Sell
1,028
-211
-17% -$886 ﹤0.01% 3313
2025
Q4 		$4.28K Hold
1,239
– – ﹤0.01% 3347
2025
Q3 		$6.33K Sell
1,239
-1,896
-60% -$9.89K ﹤0.01% 3352
2025
Q2 		$16.6K Buy
3,135
+389
+14% +$2.83K ﹤0.01% 3092
2025
Q1 		$22.3K Sell
2,746
-3
-0.1% -$28 ﹤0.01% 2907
2024
Q4 		$35.2K Sell
2,749
-29
-1% -$342 ﹤0.01% 2846
2024
Q3 		$29.8K Sell
2,778
-67
-2% -$629 ﹤0.01% 2902
2024
Q2 		$22.5K Buy
2,845
+126
+5% +$1.2K ﹤0.01% 2971
2024
Q1 		$43.6K Sell
2,719
-86
-3% -$1.39K ﹤0.01% 2795
2023
Q4 		$38.5K Sell
2,805
-85
-3% -$974 ﹤0.01% 2843
2023
Q3 		$42.2K Sell
2,890
-154
-5% -$2.61K ﹤0.01% 2888
2023
Q2 		$51.8K Buy
+3,044
New +$44.7K ﹤0.01% 2874
2022
Q2 		– Sell
-2,616
Closed -$22K – 3630
2022
Q1 		$22K Buy
2,616
+98
+4% +$903 ﹤0.01% 3216
2021
Q4 		$30K Hold
2,518
– – ﹤0.01% 3151
2021
Q3 		$45K Hold
2,518
– – ﹤0.01% 3006
2021
Q2 		$52K Buy
+2,518
New +$49.6K ﹤0.01% 2936

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Legal & General Group's RCEL Position: Q1 2026 in Review

Legal & General Group reduced its Avita Medical (RCEL) stake by 17% in Q1 2026, selling an estimated $886 and leaving 1,028 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3313.

Legal & General Group first reported a position in RCEL in Q2 2021 and has held it in 16 quarters since. The position peaked at $52K in Q2 2021. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Legal & General Group held 1,028 shares of Avita Medical worth $3.8K as of Q1 2026.
  • Legal & General Group sold 211 Avita Medical shares in Q1 2026, an estimated $886.
  • Avita Medical made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3313 holding.
  • Legal & General Group first reported a position in Avita Medical in Q2 2021 and has held it in 16 quarters since.
  • Legal & General Group's Avita Medical position peaked at $52K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.